News and Insights
NAI Provides Guidance on Choosing a Chief Compliance Officer in Pharmaceutical Compliance Monitor
September 1, 2012
As pharmaceutical companies struggle to meet increasing legal and regulatory requirements, what’s really critical in a chief compliance officer? NAI Consultant Stephen Rothenberg, J.D., discusses the characteristics this executive should have in his article, @BeginLink@Choosing the Right Chief Compliance Officer@EndLink@, published September 25, 2012 in Pharmaceutical Compliance Monitor. The article describes the key considerations for pharmaceutical companies in selecting a new head of compliance, and offers guidance for how these companies can best match candidate experience with their own needs.